POLYVASCULAR DISEASE AT JOSEPH RAVOAHANGY ANDRIANAVALONA: PREVALENCE AND RISK FACTORS
Keywords:Aneurism, Coronary artery disease, Cerebro-vascular disease, lower extremity artery disease, Polyvascular disease
Introduction : Polyvascular disease is a public health issue in the whole World. It is an incidental finding or it is discovered when there are manifestations due to low perfusion. The aim of this study is to report epidemiological, diagnosis and therapeutic aspects of this disease in JRA Hospital Antananarivo Madagascar.
Patients and methods. It’s a retrospective and analytic study of 446 patients, from first January 2010 to 31th December 2019.
Results :This study counted 330 men and 116 women. They are between 50 and 60 (47.53%). The main risk factors are the age, the male gender, smoking and inactivity. The discovery circumstances is the lower extremity artery disease. The anti-atheromatous treatment is the base of the management. Only one third of the patients attend the periodic check up. Among them, five percent have bad outcomes and the others have steady arterial damage.
The prevalence of multisite artery disease is higher in this study compared to the others. Some of them are performed in general population and some other in people with cerbro-vascular disease. The main background discovery is the lower extremity artery disease while in other studies, it is either the coronary artery disease or the systematic screening. The open surgery is performed here, except the sus renal aorta aneurism, the coronaropathy due to a lack of technical equipment.
Conclusion : Polyvascular disease needs to be searched in high cardio-vascular risk factors patients or in symptomatic patients. Risk factors control is the condition of an efficient management.
Key words : Aneurism ; Coronary artery disease ;Cerebro-vascular disease ; Lower extremity artery disease ; Polyvascular disease.
Subherwal S et al. Polyvascular disease and long term cardio-vascular outcomes in older patients with non ST segment elevation myocardial infarction. AHA Joornals. Jul 2012 ; 5(4) :541-9.
OMS. Country profil for noncommunicable disease.2018. Available at www.WHO.int
Tendera M et al. ESC Guidelines on the diagnosis and treatment of Peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the diagnosis and Treatment of Peripheral artery diseases of the European Society of Cardiology. Eur Heart J .2011; 32(22):2851–906.
Vlajinac H D et al. Pevalence of polyvascular disease in patient s with carotid artery disease and peripheral artery disease. Kardiol Pol. 2019; 77 (10): 926-34.
Gutierrez JA et al. Polyvascular disease and risk of malor adverse cardiovascular disease events in periphéral artery disease : a secondary analysis of the EUCLID Trial. JAMA Netw open. 2018 ;1.
Ashwinkumar V et al. Intermittent claudication : an overview. J. Atherosclerosis Sept 2006 ; 187(2) :221-37.
Criqui MH and Denenberg JO. The generalized nature of atherosclerosis: how peripheral arterial disease may predict adverse events from coronary artery disease. Vasc Med 1998; 3:241–5.
Vidakovic R et al. The prevalence of polyvascular disease in patients referred for peripheral arterial disease. Eur J vasc Endovasc Surg 2009 ; 38 :435-40.
Hur DJ et al. Frequency of coronary artery disease in patients undergoing peripheral artery disease surgery. Am J Cardiol 2012 ; 110 :736-40.
Ishihara T et al. Severity of coronary arteyr disease affects prognosis of patients with peripheral artery disease. Angiology 2013 ; 64 :417-22.
Razzouk L et al. Co-existence of vascullar disease in different arterial beds : peripheral artery disease and carotid artery disease and coronary stenosis- data from Life Line Screening. Atherosclerosis 2015 ; 241 : 687-91.
Ahmed B and Al-Khaffaf H. Prevalence of significant asymptomatic carotid artery diease in patients with peripheral vascular disease : a metanalysis. Eur J Vasc Endovasc Surg 2009 ; 37 :784-92.
Aboyans V et al. Renal artery stenosis in patients with peripheral artery disease :prevalence , risk factors and long term prognosis. Eur J Endovasc Surg. 2017 ; 53(3) :380-5.
Barba A et al. Detection of aortic aneurism in patients with peripheral artery disease. Eur J Vasc Endovasc Surg. May 2005 ; 30 :504-8.
Ashley K et al . Cardiovascular disease in Africa : epidemiological profile and challenges. Nature reviews. May 2017. 14 :273-93.
Mendy VL, Vargas R, Lamees E. Trends in heart dissease mortality among Mississipi adults over three decades, 1980-2013. Public Library of Science . Aug 2016;11:1-9.
Naylor A et al. Endovascular Surgery. Eur J vasc. 2002 ; 23:283-94
Marcelo P and Vera LP. Carotid stenosis and coronary artery disease bypass grafting. Review of brasilian medical association May 2011 ; 57 :323-7.
Bauersachs R et al. Burden of coronary artery disease and peripheric artery disease : A littérature review. Cardiovascular therapeutics Nov 2019 ; 2019 :1-9.
Ahlawat SK and Cuddihy MT. Seventy one years old woman with low back pain. Mayo Clin Proc. 2002 ;77(8) :849-52.
Hassan AT and El-Menyar Ayman. Abdominal aortic aneurisme and coronary artery disease in a small country with high cardio-vascular burden. ISRN Cardiol 2014 ; 2014 :825461.
Kosmas I et al. Abdominal aorta aneurism, peripheral artery disease and carotid artery stenosis : differents sides of the same coin ?. Angiology Apr 2016 ;67 :307-8.
David L et al. Atherosclerotic renal artery stenosis- diagnosis and treatment. Mayo Clin Proc. 2011 Jul ; 86:649-57.
Przewlocki T at al. Renal artery stenosis in patients with cronary artery stenosis. Kardiol Pol. August 2008 ; 66:856-62.
Stack R and Pile R. Renal artery stenosis : under diagnosticated and under treated in cardiac patients.J Cardiol Invasif. 1999 Feb ; 11:103-5.
Calvet D et al. Prevalence pf asymptomatic coronary artery disease in ischemic stroke patients : the Precoris study. Circulation 2010 Apr 13 ; 121:1623-9.
Bhatt DL et al. Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis. JAMA. 2010 ;304: 1350–7.
How to Cite
Copyright (c) 2022 EPH - International Journal of Medical and Health Science
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
- All contributor(s) agree to transfer the copyright of this article to EPH Journal.
- EPH Journal will have all the rights to distribute, share, sell, modify this research article with proper reference of the contributors.
- EPH Journal will have the right to edit or completely remove the published article on any misconduct happening.